ASAS-PerSpA study finds Japanese patients with axial psoriatic arthritis have lower disease activity and better function than ...

Living with ankylosing spondylitis (AS) brings its own set of challenges, especially when you think about starting a family. You might notice changes in your symptoms, energy levels, or even how your ...

Pfizer Inc. announced positive results from a phase 3 investigational study evaluating the safety and efficacy of tofacitinib in adults with active ankylosing spondylitis (AS). Tofacitinib is not ...

These are more affordable versions of original biologic drugs that are frequently the best option to treat many chronic ...

Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...

AbbVie to present data from multiple studies of Rinvoq, Humira & Skyrizi at the 2019 ACR/ARP) meeting: North Chicago, Illionis Tuesday, November 5, 2019, 16:00 Hrs [IST] AbbVie, a ...

According to DataM Intelligence, the global Disease-Modifying Therapies (DMTs) Market was valued at USD 65.32 billion in 2024 ...

As temperatures begin to dip, people with arthritis start to feel an escalation in joint pain, stiffness and discomfort. In fact, most people feel that in winter months their arthritis symptoms ...

According to DataM Intelligence, the global Disease-Modifying Therapies (DMTs) Market was valued at USD 65.32 billion in 2024 and is projected ...

Arthritis is one of the leading causes of disability worldwide. It accounts for a significant percentage of years lived with ...

Bhubaneswar: Manipal Hospital Bhubaneswar successfully restoring mobility to a 35-year-old woman from Odisha who had been ...

A self-referral tool for patients with chronic back pain may be a feasible solution for identifying axial spondyloarthritis, ...